IONS ▼ -1.3% - Ionis Pharmaceuticals, Inc.
$IONS TRYNGOLZA® (olezarsen) recommended for approval in the EU by CHMP for severe hypertriglyceridemia (sHTG)
16-OCT-2026 06:45 AM ET
Share this post
More filings for $IONS
IONS ▲ +3.6% - Ionis Pharmaceuticals, Inc.Sep 23, 2026IONS ▲ +3.7% - Ionis Pharmaceuticals, Inc.Sep 22, 2026IONS ▲ +3.3% - Ionis Pharmaceuticals, Inc.Sep 22, 2026IONS ▼ -6.3% - Ionis Pharmaceuticals, Inc.Sep 4, 2026IONS ▼ -5.1% - Ionis Pharmaceuticals, Inc.Sep 3, 2026
View full $IONS filing history →💬 Comments
Loading comments…
Leave a comment